OXFORD BIOSCIENCE PARTNERS IV LP's Net Worth
$57.7 Million
Who is OXFORD BIOSCIENCE PARTNERS IV LP?
OXFORD BIOSCIENCE PARTNERS IV LP has an estimated net worth of $57.7 Million. This is based on reported shares across multiple companies, which include Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., ACADIA PHARMACEUTICALS INC, Solexa, Inc., IMCOR PHARMACEUTICAL CO, and SIRNA THERAPEUTICS INC.
SEC CIK
OXFORD BIOSCIENCE PARTNERS IV LP's CIK is 0001140484
Past Insider Trading and Trends
2005 was OXFORD BIOSCIENCE PARTNERS IV LP's most active year for acquiring shares with 18 total transactions. OXFORD BIOSCIENCE PARTNERS IV LP's most active month to acquire stocks was the month of June. 2003 was OXFORD BIOSCIENCE PARTNERS IV LP's most active year for disposing of shares, totalling 17 transactions. OXFORD BIOSCIENCE PARTNERS IV LP's most active month to dispose stocks was the month of October. 2004 saw OXFORD BIOSCIENCE PARTNERS IV LP paying a total of $19,749,279.90 for 26,555,987 shares, this is the most they've acquired in one year. In 2004 OXFORD BIOSCIENCE PARTNERS IV LP cashed out on 16,509,854.39 shares for a total of $9,418,612.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trubion Pharmaceuticals, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5,180.19% | 2.16M |
—
|
—
| 2.2M |
Oct 23
| |||
Form 4
|
∞
| 41.61K |
$13.00 | $540,982.00 | 41.61K |
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyberkinetics Neurotechnology Systems, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.58% | 833.33K |
$1.20 | $1,000,000.80 | 10.54M |
Oct 18
| |||
Form 4
| +34.69% | 2.5M |
$1.20 | $3,000,000.00 | 9.71M |
Sep 26
| |||
Form 4
| +4.62% | 318.5K |
$3.00 | $955,503.00 | 7.21M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $25.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
| +22.78% | 586.4K |
$6.82 | $4,000,023.96 | 3.16M |
Apr 20
| |||
Form 4
| +112.31% | 2.6M |
$7.00 | $1,995,000.00 | 4.91M |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Solexa, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -65.67% | -2.00M |
—
|
—
| 1.05M |
Jan 18
| |||
Form 4
| +22.14% | 552.01K |
$4.00 |
—
| 3.05M |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMCOR PHARMACEUTICAL CO No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.11% | 49.79K |
$0.35 | $17,425.10 | 44.56M |
Jan 10
| |||
Form 4
| +37.37% | 7.09M |
$0.75 | $5,317,683.46 | 26.07M |
Apr 14 - Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||